The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Shingles Vaccine Market Research Report 2024
Synopsis
The global Shingles Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Shingles Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Shingles Vaccine.
Report Scope
The Shingles Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Shingles Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Shingles Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GlaxoSmithKline
Segment by Type
Zostavax
Shingrix
Segment by Application
Under 50 Years Old
50-60 Years Old
60-70 Years Old
Above 70 Years Old
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Shingles Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Shingles Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Shingles Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global Shingles Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Shingles Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Shingles Vaccine.
Report Scope
The Shingles Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Shingles Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Shingles Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GlaxoSmithKline
Segment by Type
Zostavax
Shingrix
Segment by Application
Under 50 Years Old
50-60 Years Old
60-70 Years Old
Above 70 Years Old
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Shingles Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Shingles Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Shingles Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Shingles Vaccine Market Overview
1.1 Product Definition
1.2 Shingles Vaccine Segment by Type
1.2.1 Global Shingles Vaccine Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Zostavax
1.2.3 Shingrix
1.3 Shingles Vaccine Segment by Application
1.3.1 Global Shingles Vaccine Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Under 50 Years Old
1.3.3 50-60 Years Old
1.3.4 60-70 Years Old
1.3.5 Above 70 Years Old
1.4 Global Market Growth Prospects
1.4.1 Global Shingles Vaccine Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Shingles Vaccine Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Shingles Vaccine Production Estimates and Forecasts (2019-2030)
1.4.4 Global Shingles Vaccine Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Shingles Vaccine Production Market Share by Manufacturers (2019-2024)
2.2 Global Shingles Vaccine Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Shingles Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Shingles Vaccine Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Shingles Vaccine, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Shingles Vaccine, Product Offered and Application
2.8 Global Key Manufacturers of Shingles Vaccine, Date of Enter into This Industry
2.9 Shingles Vaccine Market Competitive Situation and Trends
2.9.1 Shingles Vaccine Market Concentration Rate
2.9.2 Global 5 and 10 Largest Shingles Vaccine Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Shingles Vaccine Production by Region
3.1 Global Shingles Vaccine Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Shingles Vaccine Production Value by Region (2019-2030)
3.2.1 Global Shingles Vaccine Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Shingles Vaccine by Region (2025-2030)
3.3 Global Shingles Vaccine Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Shingles Vaccine Production by Region (2019-2030)
3.4.1 Global Shingles Vaccine Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Shingles Vaccine by Region (2025-2030)
3.5 Global Shingles Vaccine Market Price Analysis by Region (2019-2024)
3.6 Global Shingles Vaccine Production and Value, Year-over-Year Growth
3.6.1 North America Shingles Vaccine Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Shingles Vaccine Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Shingles Vaccine Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Shingles Vaccine Production Value Estimates and Forecasts (2019-2030)
4 Shingles Vaccine Consumption by Region
4.1 Global Shingles Vaccine Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Shingles Vaccine Consumption by Region (2019-2030)
4.2.1 Global Shingles Vaccine Consumption by Region (2019-2024)
4.2.2 Global Shingles Vaccine Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Shingles Vaccine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Shingles Vaccine Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Shingles Vaccine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Shingles Vaccine Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Shingles Vaccine Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Shingles Vaccine Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Shingles Vaccine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Shingles Vaccine Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Shingles Vaccine Production by Type (2019-2030)
5.1.1 Global Shingles Vaccine Production by Type (2019-2024)
5.1.2 Global Shingles Vaccine Production by Type (2025-2030)
5.1.3 Global Shingles Vaccine Production Market Share by Type (2019-2030)
5.2 Global Shingles Vaccine Production Value by Type (2019-2030)
5.2.1 Global Shingles Vaccine Production Value by Type (2019-2024)
5.2.2 Global Shingles Vaccine Production Value by Type (2025-2030)
5.2.3 Global Shingles Vaccine Production Value Market Share by Type (2019-2030)
5.3 Global Shingles Vaccine Price by Type (2019-2030)
6 Segment by Application
6.1 Global Shingles Vaccine Production by Application (2019-2030)
6.1.1 Global Shingles Vaccine Production by Application (2019-2024)
6.1.2 Global Shingles Vaccine Production by Application (2025-2030)
6.1.3 Global Shingles Vaccine Production Market Share by Application (2019-2030)
6.2 Global Shingles Vaccine Production Value by Application (2019-2030)
6.2.1 Global Shingles Vaccine Production Value by Application (2019-2024)
6.2.2 Global Shingles Vaccine Production Value by Application (2025-2030)
6.2.3 Global Shingles Vaccine Production Value Market Share by Application (2019-2030)
6.3 Global Shingles Vaccine Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Merck
7.1.1 Merck Shingles Vaccine Corporation Information
7.1.2 Merck Shingles Vaccine Product Portfolio
7.1.3 Merck Shingles Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Merck Main Business and Markets Served
7.1.5 Merck Recent Developments/Updates
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Shingles Vaccine Corporation Information
7.2.2 GlaxoSmithKline Shingles Vaccine Product Portfolio
7.2.3 GlaxoSmithKline Shingles Vaccine Production, Value, Price and Gross Margin (2019-2024)
7.2.4 GlaxoSmithKline Main Business and Markets Served
7.2.5 GlaxoSmithKline Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Shingles Vaccine Industry Chain Analysis
8.2 Shingles Vaccine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Shingles Vaccine Production Mode & Process
8.4 Shingles Vaccine Sales and Marketing
8.4.1 Shingles Vaccine Sales Channels
8.4.2 Shingles Vaccine Distributors
8.5 Shingles Vaccine Customers
9 Shingles Vaccine Market Dynamics
9.1 Shingles Vaccine Industry Trends
9.2 Shingles Vaccine Market Drivers
9.3 Shingles Vaccine Market Challenges
9.4 Shingles Vaccine Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
